Highly experienced in method development by using advanced high performance liquid chromatography with mass spectrometry (LC/MS): Characterization and quantitation of different type of gene therapy vectors (non-enveloped (AAV, AV) or enveloped viral vector (Lentiviral Vector)); Analysis of life attenuated vaccine product (enveloped virus); Stability study, forced degradation study and method qualification of biologic drugs such as antibody and enzyme, helping to support drug development in early stages or clinical stages. Skilled in sequence and PTM analysis, intact and subunit analysis, disulfide mapping, glycan and glycopeptide analysis, host cell protein analysis.